Drug application
NICOTINE POLACRILEX (NICOTINE POLACRILEX)
Drugs@FDA ANDA 203690 · PPI-DAC
Key facts
| Drug name | NICOTINE POLACRILEX |
|---|---|
| Active ingredients | NICOTINE POLACRILEX |
| Application type | ANDA |
| Application number | 203690 |
| Company | PPI-DAC |
| Dosage forms | TROCHE/LOZENGE, ORAL |
| Strength | EQ 2MG BASE |
| Marketing status | Over-the-counter |
| Reference listed drug | No |
| Latest submission status date | Oct 9, 2012 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.